Pet Therapeutic Diet Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Wet Food, Dry Food, Others), By Animal Type (Dogs, Cats, Others), By Indication (Renal Care, Obesity Care, Diabetic Care, Dental Care, Gastrointestinal Care, Recovery Care, Others), Distribution Channel (E-commerce, Veterinary Hospitals & Clinics, Retail Pharmacies, Others), By Region and Competition, 2020-2030F

Market Overview

Global Pet Therapeutic Diet Market was valued at USD 2.45 Billion in 2024 and is expected to reach USD 3.70 Billion by 2030 with a CAGR of 7.10% during the forecast period. The global pet therapeutic diet market is experiencing robust growth, driven by rising pet ownership, increasing humanization of pets, and the growing prevalence of chronic health conditions such as obesity, diabetes, kidney disease, and gastrointestinal disorders. Pet owners are increasingly seeking specialized, veterinary-recommended diets that provide condition-specific nutrition and overall wellness benefits. Dry food remains the leading format due to its convenience, long shelf life, and dental health benefits, while dogs dominate the market owing to their larger population and diverse dietary requirements. North America leads the market, supported by high pet ownership, strong consumer awareness, and well-established veterinary and distribution networks.

Key trends shaping the market include the integration of functional ingredients, personalized nutrition, sustainable and ethically sourced diets, technological innovations in pet care, and expansion of e-commerce and veterinary channels. Despite high growth potential, challenges such as the premium cost of therapeutic diets, regulatory complexities, limited awareness in some regions, and palatability issues may constrain market expansion. Overall, the market is poised for continued growth as pet owners increasingly prioritize the health and well-being of their animals.

Key Market Drivers

Rising Prevalence of Chronic Health Conditions in Pets

The increasing prevalence of chronic health conditions in pets is a significant driver of the global pet therapeutic diet market. As pets live longer and human-animal bonds strengthen, pet owners are more attuned to their companions' health needs, prompting a surge in demand for specialized diets.

Obesity remains the most prevalent chronic condition in pets. According to the 2022 U.S. Pet Obesity Prevalence Survey, 59% of dogs and 61% of cats were classified as overweight or obese. This marks an increase from previous years, highlighting a persistent upward trend in pet obesity rates. Obesity in pets is associated with various health complications, including diabetes, osteoarthritis, and cardiovascular diseases. For instance, obese cats are 2–4 times more likely to develop diabetes mellitus. These conditions necessitate specialized therapeutic diets to manage and mitigate associated risks.

Diabetes is another prevalent chronic condition in pets, particularly among obese cats. The majority of diabetic cats suffer from Type 2 diabetes or insulin resistance, conditions closely linked to obesity. Managing diabetes in pets requires precise dietary control to regulate blood glucose levels and prevent complications.

Chronic Kidney Disease is a common ailment in aging pets, especially cats. The condition leads to a gradual decline in kidney function, necessitating dietary adjustments to manage symptoms and slow progression. Therapeutic diets formulated for CKD typically feature controlled protein levels, enhanced palatability, and increased moisture content to support kidney health.

Gastrointestinal disorders, such as inflammatory bowel disease (IBD), are prevalent in both dogs and cats. These conditions cause chronic inflammation of the gastrointestinal tract, leading to symptoms like vomiting, diarrhea, and weight loss. Therapeutic diets for gastrointestinal disorders often include novel protein sources, prebiotics, and fiber to support digestive health and reduce inflammation.

The escalating prevalence of chronic health conditions in pets underscores the need for specialized therapeutic diets. As pet owners become more proactive in managing their pets' health, the demand for tailored nutritional solutions is poised to continue its upward trajectory, driving growth in the pet therapeutic diet market.

Increasing Pet Humanization

The trend of pet humanization, where pets are increasingly viewed as integral members of the family, is profoundly shaping the pet care landscape. Pet owners are no longer satisfied with basic nutrition; they seek high-quality, specialized diets that cater to their pets’ unique health needs. This shift has driven a marked increase in demand for therapeutic diets that help manage chronic health conditions such as obesity, diabetes, and kidney disease.

Emotional attachment plays a significant role in this trend. Pets are seen as companions and family members, and owners often extend the same level of care to their pets as they do to themselves. As a result, diets that were once considered niche or veterinary-exclusive are now in high demand among general pet owners. This behavioral change is encouraging companies to develop more palatable, nutritionally advanced therapeutic foods that align with human dietary standards.

The growth of the pet care industry reflects this humanization trend. In 2023, global pet care spending reached an impressive USD 197.6 billion, marking a 5.9% increase from the previous year. This increase demonstrates the willingness of pet owners to invest more in their pets’ health and wellness, particularly through premium and condition-specific products.

Awareness and education about pet health have also fueled this trend. Pet owners are increasingly informed about the impact of nutrition on long-term health, largely due to accessible resources such as veterinary consultations, online guides, and social media communities. Studies indicate that approximately 70% of pet owners actively research their pets’ diets before making a purchase, reflecting a shift toward informed decision-making and personalized nutrition.

Another factor contributing to the rise of therapeutic diets is the premiumization of pet products. There is a growing preference for high-quality ingredients, functional formulations, and foods that address specific health concerns. Recent surveys show that over 60% of pet owners are willing to pay a premium for products that enhance their pets’ overall wellness, and demand for condition-specific diets has risen sharply over the past five years.

The humanization trend is encouraging innovation and diversification within the market. Companies are responding with a broader range of products, from renal-support diets to gastrointestinal health formulations, often emphasizing natural ingredients, functional additives, and scientific backing. The shift toward preventive and condition-specific nutrition is reshaping the pet therapeutic diet sector, making it more consumer-centric and growth-oriented.

Download Free Sample Report

Key Market Challenges

High Cost of Therapeutic Diets

One of the most pressing challenges in the global pet therapeutic diet market is the relatively high cost of these specialized products compared to standard pet foods. Therapeutic diets are formulated using high-quality, condition-specific ingredients designed to manage chronic health issues in pets, such as obesity, diabetes, kidney disease, and gastrointestinal disorders. These ingredients, which often include hydrolyzed proteins, novel proteins, fiber blends, and functional additives, are typically more expensive than conventional pet food ingredients. Additionally, research and development costs associated with creating scientifically validated diets contribute to the premium pricing of these products.

The elevated cost of therapeutic diets poses a barrier to adoption for many pet owners, particularly in price-sensitive markets. While pet owners recognize the health benefits of these specialized diets, sustaining long-term use can be financially challenging, especially for pets that require lifelong dietary management. For example, a dog or cat diagnosed with chronic kidney disease may need a therapeutic diet for several years, resulting in significant cumulative expenses. In regions where disposable income is lower or where pet insurance coverage is limited, the high cost can deter pet owners from choosing therapeutic diets, leading to reliance on standard pet foods or alternative solutions.

The premium pricing also affects repeat purchase behavior. Even if pet owners initially invest in therapeutic diets, affordability concerns may result in inconsistent feeding or early discontinuation, reducing the efficacy of the diet and potentially slowing market growth. To overcome this challenge, manufacturers are exploring strategies such as offering smaller packaging, subscription-based models, and region-specific pricing to make therapeutic diets more accessible without compromising quality. Addressing the cost barrier is essential for wider market penetration and long-term growth in the global pet therapeutic diet segment.

Key Market Trends

Integration of Functional Ingredients

The integration of functional ingredients into pet therapeutic diets is emerging as a pivotal trend in the global market, reflecting pet owners’ growing focus on overall health and wellness. Beyond addressing specific health conditions, modern pet owners increasingly demand diets that provide additional health benefits, such as supporting digestive health, improving skin and coat quality, and enhancing cognitive function. To meet these needs, manufacturers are incorporating scientifically backed functional ingredients such as probiotics, prebiotics, omega-3 fatty acids, antioxidants, and fiber blends into therapeutic formulations.

Probiotics, for instance, have become a cornerstone of gastrointestinal support in both cats and dogs. By introducing beneficial bacteria into the gut, probiotics help maintain a balanced microbiome, which can improve nutrient absorption, reduce gastrointestinal discomfort, and support immune function. Veterinary experts note that while the canine and feline microbiomes are less studied than those of humans, evidence suggests that probiotics can assist with conditions like acute diarrhea, inflammatory bowel disease, and even weight management in pets. Similarly, prebiotics serve as dietary fibers that nourish these beneficial bacteria, enhancing their effectiveness and supporting overall gut health.

In addition to digestive benefits, omega-3 fatty acids and antioxidants play crucial roles in systemic health. Omega-3s, such as EPA and DHA, contribute to cardiovascular health, reduce inflammation, and support skin and coat condition. Antioxidants like vitamins C and E help neutralize free radicals, supporting cellular health and potentially improving cognitive function in aging pets.

The inclusion of these functional ingredients has positioned therapeutic diets as more than just medical foods, they are now seen as comprehensive health solutions. By addressing multiple aspects of wellness simultaneously, these diets not only manage chronic conditions but also promote preventive care, ultimately increasing adherence among pet owners and driving sustained market growth.

Segmental Insights

Product Insights

Dry food continues to dominate the global pet therapeutic diet market due to its convenience, longer shelf life, and cost-effectiveness compared to wet or semi-moist alternatives. Pet owners often prefer dry diets because they are easy to store, serve, and measure accurately, which is especially important for managing portion control in pets with chronic conditions such as obesity, diabetes, and kidney disease. Additionally, dry therapeutic diets typically offer a higher concentration of nutrients per serving and can be formulated to meet specific dietary requirements. The texture of kibble also aids in dental health by reducing plaque and tartar buildup, further enhancing its appeal. The combination of affordability, practicality, and proven health benefits has solidified dry food’s position as the leading format in the therapeutic diet segment, particularly in regions where pet owners prioritize long-term dietary management for their pets.

Animal Type Insights

Dogs have emerged as the dominant segment in the global pet therapeutic diet market due to their high popularity as companion animals and the rising incidence of chronic health conditions among them. Conditions such as obesity, diabetes, gastrointestinal disorders, and kidney disease are increasingly common in dogs, driving demand for specialized diets that manage these issues. Dogs also tend to have more diverse dietary needs across life stages, breeds, and activity levels, making them prime candidates for condition-specific therapeutic nutrition. Additionally, strong emotional bonds between dog owners and their pets often translate into greater willingness to invest in high-quality, vet-recommended diets. The growing trend of pet humanization further reinforces this pattern, as owners seek products that enhance overall health, longevity, and quality of life for their dogs, thereby positioning dogs as the largest consumer base in the therapeutic diet market.

Download Free Sample Report

Regional Insights

North America has consistently dominated the global pet therapeutic diet market due to high pet ownership rates, strong humanization trends, and widespread awareness of pet health and nutrition. The region has one of the highest numbers of companion animals per household, with dogs and cats increasingly considered family members, which drives demand for premium and condition-specific diets. Additionally, North American consumers are highly informed about chronic pet health conditions such as obesity, diabetes, and kidney disease, and they actively seek veterinary-recommended solutions to manage these issues. The well-established veterinary infrastructure, combined with strong distribution channels including clinics, specialty stores, and e-commerce platforms, ensures easy access to therapeutic diets. Furthermore, disposable income levels and willingness to invest in pets’ health contribute to the region’s market dominance, making North America the largest and most mature market for therapeutic pet nutrition globally.

Recent Development

• In July 2025, Farmina Pet Foods has entered into a national distribution agreement with MWI Animal Health, a leading veterinary supply company, to expand access to its VetLife therapeutic diet line across the U.S. veterinary channel. The agreement encompasses Farmina’s full VetLife portfolio, which includes formulations addressing dermatological, renal, gastrointestinal, urinary, and metabolic conditions in both dogs and cats. The diets are crafted with non-GMO ingredients and free from artificial preservatives, ensuring high-quality, science-backed nutrition for pets with specific health needs. 
• In August 2024, Rossari Biotech’s Pet Care division introduced Vetsense, a new line of prescription diets designed to support pet health, at IVACON 2024. The initial portfolio includes formulations for gastrointestinal support, weight management, dermatological care, and a weaning supplement. Developed with natural ingredients and veterinary expertise, Vetsense aims to meet therapeutic requirements while promoting overall vitality in pets.
• In April 2024, Royal Canin U.S. broadened its Veterinary Gastrointestinal range with five new diets targeting digestive health in cats and dogs. The new offerings include hydrolyzed protein, low-fat, and high-fiber formulations designed to manage food sensitivities, promote microbiome balance, and address common gastrointestinal issues, reflecting the company’s commitment to science-based therapeutic nutrition.
• In January 2024, At VMX 2024, Hill’s Pet Nutrition unveiled advancements in its Prescription Diet line, introducing formulas that address digestive, urinary, and stress-related conditions in pets. Key launches include z/d Low Fat Canine, c/d Multicare Low Fat Canine, and enhanced feline GI and stress-support diets. Hill’s also emphasizes weight management through specialized tools and resources, supporting veterinarians and pet owners in combating pet obesity effectively.

Key Market Players

• Colgate-Palmolive Company (Hill's Pet Nutrition Inc.)
• Nestlé S.A.
• Mars, Incorporated
• General Mills Inc. (Blue Buffalo Company, Ltd.)
• SCHELL & KAMPETER, INC. (DIAMOND PET FOODS)
• Virbac Corporation
• Veterinary Nutrition Group Pty Ltd
• Farmina Pet Foods
• JustFoodForDogs
• EmerAid, LLC

Report Scope

In this report, the Global Pet Therapeutic Diet Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Pet Therapeutic Diet Market, By Product:

o   Wet Food

o   Dry Food

o   Others

• Pet Therapeutic Diet Market, By Animal Type:

o   Dogs

o   Cats

o   Others

• Pet Therapeutic Diet Market, By Indication:

o   Renal Care

o   Obesity Care

o   Diabetic Care

o   Dental Care

o   Gastrointestinal Care

o   Recovery Care

o   Others

• Pet Therapeutic Diet Market, By Distribution Channel:

o   E-commerce

o   Veterinary Hospitals & Clinics

o   Retail Pharmacies

o   Others

• Pet Therapeutic Diet Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pet Therapeutic Diet Market.

Available Customizations:

Global Pet Therapeutic Diet Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Pet Therapeutic Diet Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]